Morgan Stanley Call 12 DVAX 20.09.../ DE000ME9SK66 /
| 6/21/2024 9:08:38 PM | Chg.-0.040 | Bid10:00:35 PM | Ask10:00:35 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.620EUR | -6.06% | - Bid Size: - |
- Ask Size: - |
Dynavax Technologies... | 12.00 USD | 9/20/2024 | Call |
GlobeNewswire
5/15
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
3/6
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Va...
GlobeNewswire
1/8
Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical O...
GlobeNewswire
3/1/2022
Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA20...
GlobeNewswire
2/25/2022
Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate V...
GlobeNewswire
1/25/2022
Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine Candidate
GlobeNewswire
1/19/2022
Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant
GlobeNewswire
1/6/2022
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vac...
GlobeNewswire
12/23/2021
Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site
GlobeNewswire
12/16/2021
Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Cand...
GlobeNewswire
12/8/2021
Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001
GlobeNewswire
12/2/2021
Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine ...
GlobeNewswire
11/29/2021
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2...
GlobeNewswire
11/23/2021
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA20...
GlobeNewswire
11/10/2021
Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million D...
GlobeNewswire
11/4/2021
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results
GlobeNewswire
11/2/2021
Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel
GlobeNewswire
10/18/2021
Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2...
GlobeNewswire
9/23/2021
Valneva Continues Expansion of Clinical Trials of its Inactivated COVID-19 Vaccine Candidate VLA2001
GlobeNewswire
9/14/2021
Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 V...
GlobeNewswire
9/13/2021
Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government
